Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03263390 · ClinicalTrials.gov registry record
Modeling the Neurological Basis and Characterizing the Neurological Phenotype of Obesity Using Human Neural Stem Cells
A clinical trial, sponsored by University of California, San Diego.
- Terminated
- Registry status
- 6
- Enrollment target
NCT03263390: Clinical Trial study, sponsored by University of California, San Diego.
NCT03263390 is a clinical trial that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03263390 was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
This study aims to characterize the neurological basis of obesity and response to surgical and medical treatment by inducing adult pluripotent stem cells into neuronal cells from subjects that have demonstrated extreme response to bariatric surgery or pharmacological treatment for obesity.
Primary Outcome
Perform DNA sequencing from skin biopsy progenitor cells
Interventions
- PROCEDURE Bariatric Surgery
- DRUG Anti Obesity Drugs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-10-05 |
| Est. Completion | 2020-08-10 |
Why NCT03263390 stopped before completion
NCT03263390 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Bariatric Surgery is the first listed.
NCT03263390 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03263390 about?
NCT03263390 is a clinical study titled "Modeling the Neurological Basis and Characterizing the Neurological Phenotype of Obesity Using Human Neural Stem Cells". This study aims to characterize the neurological basis of obesity and response to surgical and medical treatment by inducing adult pluripotent stem cells into neuronal cells from subjects that have demonstrated extreme response to bariatric surgery or pharmacological treatment for obesity.
What is the current status of trial NCT03263390?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2017-10-05. Estimated completion is 2020-08-10.
What interventions are being tested in trial NCT03263390?
The interventions under investigation include: Bariatric Surgery (PROCEDURE), Anti Obesity Drugs (DRUG).
Who is sponsoring clinical trial NCT03263390?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI